In a letter to lawyers for Novo…
In a letter to lawyers for Novo and Metsera, an [...]
In a letter to lawyers for Novo and Metsera, an [...]
Novo Nordisk is winding down a range of early-stage programs [...]
Less than two years after emerging, Arena BioWorks is shuttering, [...]
Pfizer has axed 11 programs including two pipeline assets from [...]
Questex has acquired The Conference Forum and Versalinx Global Events, [...]
Tempero Bio has hit the brakes on a phase 2-stage [...]
FDA is said to be making a U-turn on uniQure’s [...]
Roche may have been exploring ways to shuttle drugs to [...]
Welcome to the Fierce Biotech Graveyard, our annual ritual remembering [...]
Nanobiotix is continuing to find fresh ways to eke money [...]